SCHEMBL6537590

SCHEMBL6537590

Nc1cc(F)cc2c(Cl)ccnc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 3/20 0.43
MMP14 P50281 3/20 0.42
G6PD P11413 1/20 0.40
PIM1 P11309 1/20 0.38
PIM3 Q86V86 1/20 0.38
SOS2 Q07890 1/20 0.36
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 4/20 0.35
HSP90AA1 P07900 4/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
TDP1 Q9NUW8 3/20 0.35
MAPT P10636 3/20 0.35
HSP90AB1 P08238 2/20 0.35
LMNA P02545 2/20 0.35
TP53 P04637 2/20 0.35
CYP3A4 P08684 2/20 0.35
ALOX15 P16050 2/20 0.35
ALOX12 P18054 2/20 0.35
SLC6A2 P23975 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
4-Chloro-6,8-Difluoroquinoline SCHEMBL30225421 0.81 CDK8 (0.43) NR4A2MMP14KDM4EALDH1A1HSP90AA1
SCHEMBL6537786 0.81 NR4A2 (0.46) NR4A2MMP14G6PDPIM1PIM3
4-Chloro-6,8-Difluoroquinoline SCHEMBL264453 0.81 CDK8 (0.43) NR4A2MMP14KDM4EALDH1A1HSP90AA1
SCHEMBL6537871 0.79 NR4A2 (0.43) NR4A2MMP14G6PDPIM1PIM3
SCHEMBL11545025 0.79 CCR1 (0.48) G6PDPIM1PIM3KDM4EHSP90AA1
SCHEMBL6537370 0.78 SLC40A1 (0.44) NR4A2MMP14G6PDPIM1PIM3
SCHEMBL24009363 0.75 PDE2A (0.42) G6PDKDM4EHSP90AA1TDP1MAPT
SCHEMBL2270856 0.75 HSP90AA1 (0.52) NR4A2MMP14G6PDPIM1PIM3
SCHEMBL31399685 0.73 NR4A2 (0.37) NR4A2MMP14SOS2KDM4EALDH1A1
SCHEMBL6538436 0.72 ALDH1A1 (0.61) KDM4EALDH1A1HSP90AA1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed